O’Melveny represented Tianhui Biotech in the transaction. Tianhui Biotech Co., Ltd. (“Tianhui Biotech”) announced a series of agreements with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (“Oramed”). Under...
You must be a Standard 1 Year member to access this content.
O’Melveny represented the underwriters in the offering. UP Fintech Holding Limited (Tiger Brokers) (Nasdaq: TIGR) closed its US$108 million follow-on offering. Tiger Brokers offered 17.25 million...
You must be a Standard 1 Year member to access this content.
O’Melveny represented Chenghe Acquisition II Co. in the transaction. Chenghe Acquisition II Co. (NYSE: CHEB.U) announced its initial public offering on the New York Stock Exchange....
You must be a Standard 1 Year member to access this content.
